06 Feb 2024 | 04:00 PM GMT

Obesity Management: Convergence Of Market Shaping Drugs And Virtual Care

Participants:

Lauren Bataille Head, R&D Digital - CVRMAstraZeneca
Lauren Bataille
Head, R&D Digital - CVRMAstraZeneca
Nita Thingalaya NA Medical Innovation LeadSanofi
Nita Thingalaya
NA Medical Innovation LeadSanofi
Alex Gilbert VP Life SciencesAmalgamRx
Alex Gilbert
VP Life SciencesAmalgamRx
Benjamin Alouf Chief Medical OfficerFloreo
Benjamin Alouf
Chief Medical OfficerFloreo
Eva Gendolla Digital Innovation Hub PartnerNovo Nordisk
Eva Gendolla
Digital Innovation Hub PartnerNovo Nordisk
Jay Canter BDActiGraph Corporation
Jay Canter
BDActiGraph Corporation
John Bailey Vice President - Pharma SalesActiGraph
John Bailey
Vice President - Pharma SalesActiGraph
Jonas Duss Principal / Founder1sourcehealth.com
Jonas Duss
Principal / Founder1sourcehealth.com
Jonathan Lake Senior Director, Digital Endpoint ConsultantActiGraph
Jonathan Lake
Senior Director, Digital Endpoint ConsultantActiGraph
Mark Grossman VP of Growth Initiatives & Market PartnersGoMo Health - Engagement that Works
Mark Grossman
VP of Growth Initiatives & Market PartnersGoMo Health - Engagement that Works
Matt Norton VP of Marketing & Commercial DevelopmentS3 Connected Health
Matt Norton
VP of Marketing & Commercial DevelopmentS3 Connected Health
Raquel Torres González Workplace Health SolutionsAXA Health
Raquel Torres González
Workplace Health SolutionsAXA Health
Sander van den Ende CCO - Chief Commercial OfficerHedia ApS
Sander van den Ende
CCO - Chief Commercial OfficerHedia ApS
Tim Juergens PartnerCrossroad Biotech
Tim Juergens
PartnerCrossroad Biotech
Ventsislav Dobrev Global Clinical Lead Digital BiomarkersRoche
Ventsislav Dobrev
Global Clinical Lead Digital BiomarkersRoche
VJ Bala VP Marketing Partnerships & GrowthResmed
VJ Bala
VP Marketing Partnerships & GrowthResmed
Yury Rozenman SVP, Business DevelopmentPropeller Health
Yury Rozenman
SVP, Business DevelopmentPropeller Health

About this Meeting

The combination of market-shaping drugs and virtual care offers a promising solution to the complex and widespread problem of obesity. It provides targeted and personalised treatments for weight loss and management. 


Leveraging remote monitoring, teleconsultations, and other features of digital health platforms, a focused and integrated approach can enhance treatment outcomes while improving patient engagement. 


Join your peers to discuss the merits of a combination approach in obesity management and delve deep into the following themes:


  • What digital health solutions hold the greatest promise in enhancing the effectiveness of market-shaping drugs in obesity management?  
  • What strategies can be employed to effectively integrate combination approaches into current care models and workflows?  
  • What challenges and considerations should healthcare leaders address to ensure equitable access to market-shaping drugs and virtual care for individuals with obesity?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.